(PSYCHIATRIC TIMES) - Recent reports have noted an alarming decrease in the practice of psychotherapy among psychiatrists. This trend may be largely the result of reduced reimbursement for psychotherapy treatments, a reductionist view of biological research, or less emphasis on “talking therapy” in residency training.1,2
In 2001, the Residency Review Committee (RRC) mandated psychotherapy training for psychiatry residents.3 Before the RRC’s mandated curriculum, psychotherapy training was often “hit or miss” among residency training programs.
Specific changes mandated by the RRC
In 2001, the RRC’s 5 original core competencies required that residents must be able to apply supportive,psychodynamic, cognitive-behavioral therapy (CBT), and brief psychotherapies as well as combined medication and psychotherapy, with exposure to family, couples, group, and other individual evidence-based psychotherapies. Finding trained faculty to teach all 5 competencies strained many residency programs. Economic limitations and funding cuts in university-based training programs often reduce residents’ time with clinical and research faculty, who are pressured to generate personal income and support operating costs for their institutions.
July 2007 updates of the core psychotherapy competencies require training in only 3 areas: psychodynamic therapy, CBT, and supportive therapy. Residents must have an equivalent of 12 months of full-time, organized, continuous, supervised clinical experience in the assessment, diagnosis, and treatment of outpatients in both short-term and long-term care.3
Medical training at all levels and in all medical specialties has increasingly emphasized the provision of evidence-based treatments. To boost acceptance and use of psychotherapy by residents, its effectiveness must be taught through the use of rigorous clinical trials. Randomized controlled trials of treatment with psychotropic medications for psychiatric disorders are well-funded and often easier to design and carry out than psychotherapy studies, which cannot be truly blinded to patients and therapists. However, it may be argued that exclusion criteria are more stringently used in drug studies than in psychotherapy research. As a result, drug trials are more likely to eliminate patients who are representative of those seen in real clinical practice.
For full article, please visit: